Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ImmunoGen Inc.
DescriptionHumanized mAb against EGFR linked to Immunogen's DM1 cytotoxic agent
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat EGFR-positive solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today